Search research articles
Contact Us
Filters
Showing results (161-170 of 439) with videos related to
Page
of 44
Sort By:
Nature Reviews. Clinical Oncology
|
May 8, 2013
Taxane benefit in breast cancer--a role for grade and chromosomal stability
Roger P A'Hern, Mariam Jamal-Hanjani, A Marcell Szász, et al.
Nature Reviews. Disease Primers
|
March 10, 2017
Renal cell carcinoma
James J Hsieh, Mark P Purdue, Sabina Signoretti, et al.
Cancer Research
|
April 8, 2014
Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance
Charlotte K Y Ng, Britta Weigelt, Roger A'Hern, et al.
Trends in Cancer
|
June 5, 2024
Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer
Chris Abbosh, Darren Hodgson, Gary J Doherty, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 21, 2006
Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab
Thomas Yau, Charles Swanton, Sue Chua, et al.
Breast Cancer Research and Treatment
|
March 19, 2013
A 3-gene proliferation score (TOP-FOX-67) can re-classify histological grade-2, ER-positive breast cancers into low- and high-risk prognostic categories
Borbala Szekely, Takayuki Iwamoto, A Marcell Szasz, et al.
Nature Communications
|
September 26, 2022
RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma
Philip East, Gavin P Kelly, Dhruva Biswas, et al.
Cell
|
March 29, 2024
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
Antonio Passaro, Maise Al Bakir, Emily G Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Prognostic and predictive markers in metastatic renal cell carcinoma
Muhammad A Khattak, Farrah Bakr, Marcin Krzystanek, et al.
The Journal of Pathology
|
May 30, 2013
Parallel evolution of tumour subclones mimics diversity between tumours
Pierre Martinez, Nicolai Juul Birkbak, Marco Gerlinger, et al.
Page
of 44
Search research articles
Search
Showing results (161-170 of 439) with videos related to
Sort By:
Page
of 44
Nature Reviews. Clinical Oncology
|
May 8, 2013
Taxane benefit in breast cancer--a role for grade and chromosomal stability
Roger P A'Hern, Mariam Jamal-Hanjani, A Marcell Szász, et al.
Nature Reviews. Disease Primers
|
March 10, 2017
Renal cell carcinoma
James J Hsieh, Mark P Purdue, Sabina Signoretti, et al.
Cancer Research
|
April 8, 2014
Predictive performance of microarray gene signatures: impact of tumor heterogeneity and multiple mechanisms of drug resistance
Charlotte K Y Ng, Britta Weigelt, Roger A'Hern, et al.
Trends in Cancer
|
June 5, 2024
Implementing circulating tumor DNA as a prognostic biomarker in resectable non-small cell lung cancer
Chris Abbosh, Darren Hodgson, Gary J Doherty, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 21, 2006
Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab
Thomas Yau, Charles Swanton, Sue Chua, et al.
Breast Cancer Research and Treatment
|
March 19, 2013
A 3-gene proliferation score (TOP-FOX-67) can re-classify histological grade-2, ER-positive breast cancers into low- and high-risk prognostic categories
Borbala Szekely, Takayuki Iwamoto, A Marcell Szasz, et al.
Nature Communications
|
September 26, 2022
RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma
Philip East, Gavin P Kelly, Dhruva Biswas, et al.
Cell
|
March 29, 2024
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
Antonio Passaro, Maise Al Bakir, Emily G Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 9, 2013
Prognostic and predictive markers in metastatic renal cell carcinoma
Muhammad A Khattak, Farrah Bakr, Marcin Krzystanek, et al.
The Journal of Pathology
|
May 30, 2013
Parallel evolution of tumour subclones mimics diversity between tumours
Pierre Martinez, Nicolai Juul Birkbak, Marco Gerlinger, et al.
Page
of 44